AR029263A1 - A METHOD FOR DETECTING A PROTEIN COMPLEX IN THE ACUTE LIPOPROTEIN PHASE AND TO PREVENT AN INCREASED RISK OF SYSTEM FAILURE OR DEATH - Google Patents

A METHOD FOR DETECTING A PROTEIN COMPLEX IN THE ACUTE LIPOPROTEIN PHASE AND TO PREVENT AN INCREASED RISK OF SYSTEM FAILURE OR DEATH

Info

Publication number
AR029263A1
AR029263A1 ARP010102713A ARP010102713A AR029263A1 AR 029263 A1 AR029263 A1 AR 029263A1 AR P010102713 A ARP010102713 A AR P010102713A AR P010102713 A ARP010102713 A AR P010102713A AR 029263 A1 AR029263 A1 AR 029263A1
Authority
AR
Argentina
Prior art keywords
acute
death
detecting
prevent
increased risk
Prior art date
Application number
ARP010102713A
Other languages
Spanish (es)
Inventor
John A Samis
Liliana Tejidor
Cheng Hock Toh
John Walker
Timothy J Fischer
Colin Downey
Mike Nesheim
Original Assignee
Adam Worrall Julia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adam Worrall Julia filed Critical Adam Worrall Julia
Publication of AR029263A1 publication Critical patent/AR029263A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Un método que comprende: (a) el agregado de uno o más reactivos a una muestra de prueba tomada de un paciente, que comprende al menos parte de una muestra de sangre extraída de un paciente, para producir la formacion de un complejo que comprende al menos una proteína de fase aguda y al menos una lipoproteína humana, mientras que sustancialmente no se produce una polimerizacion de fibrina; (b) la medicion de la formacion de dicho complejo a lo largo del tiempo de manera de derivar un perfil de medicion que depende del tiempo; y (c) la determinacion de una pendiente y/o un cambio total en el perfil de medicion que depende del tiempo de manera de diagnosticar una condicion del paciente.A method comprising: (a) the addition of one or more reagents to a test sample taken from a patient, comprising at least part of a blood sample taken from a patient, to produce the formation of a complex comprising the less an acute phase protein and at least one human lipoprotein, while substantially no fibrin polymerization occurs; (b) the measurement of the formation of said complex over time so as to derive a measurement profile that depends on time; and (c) the determination of a slope and / or a total change in the measurement profile that depends on the time in order to diagnose a patient's condition.

ARP010102713A 2000-06-09 2001-06-07 A METHOD FOR DETECTING A PROTEIN COMPLEX IN THE ACUTE LIPOPROTEIN PHASE AND TO PREVENT AN INCREASED RISK OF SYSTEM FAILURE OR DEATH AR029263A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59164200A 2000-06-09 2000-06-09

Publications (1)

Publication Number Publication Date
AR029263A1 true AR029263A1 (en) 2003-06-18

Family

ID=24367266

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102713A AR029263A1 (en) 2000-06-09 2001-06-07 A METHOD FOR DETECTING A PROTEIN COMPLEX IN THE ACUTE LIPOPROTEIN PHASE AND TO PREVENT AN INCREASED RISK OF SYSTEM FAILURE OR DEATH

Country Status (1)

Country Link
AR (1) AR029263A1 (en)

Similar Documents

Publication Publication Date Title
DK0887421T3 (en) Diagnostic test strip with calibration on the strip
DE69912899D1 (en) Blood clot detector
DE60135147D1 (en) NEN BIOLOGICAL CELL IN A BODY FLUID TEST
AR027346A1 (en) REAGENT ANALYSIS STRIP FOR THE DETERMINATION OF ANALYTICS
EP1316802A3 (en) An ananalyzing method of a blood coagulation reaction
EP1359417A3 (en) Devices and methods for analyte concentration determination
BR0009581A (en) Test devices for detecting, and enabling the measurement of, an analyte in a fluid, and a monitoring system
ATE394658T1 (en) TRACE DETECTION OF ANALYTES USING ARTIFICIAL OLFACTOMETRY
IL136102A0 (en) Initiation of an analytical measurement
ES2117448T3 (en) POSITION DETECTABLE STRIP FOR ANALYTE DETECTION.
CA2330629A1 (en) Method and device for predicting physiological values
WO2002035232A3 (en) Method for detecting ovarian cancer based on human kallikrein 6 (hk6)
AR016908A1 (en) DEVICE, EQUIPMENT AND PROCEDURE TO DETECT THE PRESENCE OF AT LEAST ONE COMPONENT IN A BIOLOGICAL SAMPLE.
DE69033796T2 (en) METHOD AND DEVICE FOR DETECTING AND QUANTIFYING GLUCOSE IN BODY LIQUIDS
WO1998053076A3 (en) Compounds for diagnosis of tuberculosis and methods for their use
EP1445329A3 (en) Method and test strip for determining glucose in blood
AU3772495A (en) Method for specifically detecting a coagulation factor V which has an increased stability toward activated protein C in the activated state
DE50104561D1 (en) Method for the diagnosis of sepsis with determination of soluble cytokeratin fragments
BR0111987A (en) Method for detecting an acute phase lipoprotein protein complex and predicting a higher risk of system failure or mortality
BR0114514A (en) Pulp dryness measurement method, pulp and juice discharge control method and system and pulp concentration control method
AR029263A1 (en) A METHOD FOR DETECTING A PROTEIN COMPLEX IN THE ACUTE LIPOPROTEIN PHASE AND TO PREVENT AN INCREASED RISK OF SYSTEM FAILURE OR DEATH
DK1247101T3 (en) Transferrin assay
DE69920981D1 (en) KNORPELRESORPTIONSASSAYS
DE60010301D1 (en) TEST ARRANGEMENT FOR DIAGNOSIS OF MASTITIS BY DETECTING HAPTOGLOBIN
BR9510669A (en) Method for determining or detecting donor organ damage following xenotransplantation based on analytes derived from the donor organ

Legal Events

Date Code Title Description
FA Abandonment or withdrawal